68-60-0
Chemical Structure
Tetrahydro-11-deoxycortisol
Synonym(s): Tetrahydrodeoxycortisol
- CAS No.: 68-60-0
- Formula:C21H34O4
- Molecular Weight:350.49
IUPAC Name: 1-((3R,5R,8R,9S,10S,13S,14S,17R)-3,17-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxyethan-1-one
InChIKey: UPTAPIKFKZGAGM-FAIYVORSSA-N
SMILES: C[C@]1(CC2)[C@](CC[C@@]1(C(CO)=O)O)([H])[C@@]3([H])[C@@]2([H])[C@](CC[C@@H](O)C4)(C)[C@]4([H])CC3
Biological Activity: Tetrahydro-11-deoxycortisol (Tetrahydrodeoxycortisol) is an endogenous metabolite present in Urine that can be used for the research of 11 Beta Hydroxylase Deficiency[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Tetrahydro-11-deoxycortisol | 98.20% | Tetrahydro-11-deoxycortisol (Tetrahydrodeoxycortisol) is an endogenous metabolite present in Urine that can be used for the research of 11 Beta Hydroxylase Deficiency. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. [Content Brief]
- [2]. Burren CP, et al. CYP11 beta 1 (11-beta-hydroxylase) deficiency in congenital adrenal hyperplasia. J Paediatr Child Health. 1996 Oct;32(5):433-8. [Content Brief]
Keywords
